GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CannLabs Inc (OTCPK:CANL) » Definitions » Capex-to-Revenue

CannLabs (CannLabs) Capex-to-Revenue : 0.07 (As of Mar. 2015)


View and export this data going back to 2010. Start your Free Trial

What is CannLabs Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

CannLabs's Capital Expenditure for the three months ended in Mar. 2015 was $-0.03 Mil. Its Revenue for the three months ended in Mar. 2015 was $0.47 Mil.

Hence, CannLabs's Capex-to-Revenue for the three months ended in Mar. 2015 was 0.07.


CannLabs Capex-to-Revenue Historical Data

The historical data trend for CannLabs's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CannLabs Capex-to-Revenue Chart

CannLabs Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Capex-to-Revenue
Get a 7-Day Free Trial - - - 0.23 0.26

CannLabs Quarterly Data
Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.58 0.28 - 0.07

Competitive Comparison of CannLabs's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, CannLabs's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CannLabs's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CannLabs's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where CannLabs's Capex-to-Revenue falls into.



CannLabs Capex-to-Revenue Calculation

CannLabs's Capex-to-Revenue for the fiscal year that ended in Dec. 2014 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.36) / 1.365
=0.26

CannLabs's Capex-to-Revenue for the quarter that ended in Mar. 2015 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.032) / 0.47
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CannLabs  (OTCPK:CANL) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


CannLabs Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of CannLabs's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CannLabs (CannLabs) Business Description

Traded in Other Exchanges
N/A
Address
519 N. Sam Houston Parkway E., Suite 500, Houston, TX, USA, 77060
CannLabs Inc is based in Houston Texas and is a diversified inventory blockchain platform company. The company also has an entertainment division which also includes ownership of a Private Label Apparel line (Colorblind). The company is involved in four sectors: Manufacturing, Apparel, Music, and Video Game Design.

CannLabs (CannLabs) Headlines

From GuruFocus

CannLabs, Inc's 2021 Annual General Meeting Announcement

By PRNewswire PRNewswire 12-07-2021